Reporting owner · CIK 0001362489

Anderson Raymond

Visual SEC Form 4 history across 1 companies, 13 transactions and 4 filings.

DIRMonopar Therapeutics
Open-market mix
Latest filingAug 28, 2026, 11:41 PM
Filings4Form 4 records
Buying$00 purchases
Selling$703K6 sales
Net value−$703KBuys minus sells
Companies14 securities
Most recentAug 25, 2026exercise

Open-market buy performance

90-day forward return on this insider's open-market purchases

90d forward
Forward return is not available yet

We compute this from each buy's stock performance 90 days after the transaction. The price history is still being populated for this insider's their open-market buys, so the average and median will appear here once the daily price refresh has covered the relevant trading days.

Monthly open-market activity

Reported purchase and sale transaction counts

Buys Sells
1050-5-10Dec 23Mar 256Aug 26

Net value flow

Buys minus sells

Dec 23
$0
Mar 25
$0
Aug 26
−$703K

Transaction texture

Ownership and ticket size

Average P/S size$117.2K
Median P/S size$76.4K
Direct13
Indirect0
Aug 25, 2026exercise

Filing-only signals

Deterministic matches in this insider's history

Amended Filingfiling-context7Derivative Transactionfiling-context4Direct Ownershipfiling-context13Large Holdings Increaseholdings3Large Holdings Reductionholdings1Large Salesize1Repeat Sellerpattern510b5-1 Detectedfiling-context10

Latest Form 4 facts

Quick context from source filings

Latest transaction

sale at Monopar Therapeutics on Aug 25, 2026 valued at $203,716.

Review SEC filing
Latest buy

No open-market insider purchase is available.

Latest sale

sale at Monopar Therapeutics on Aug 25, 2026 valued at $203,716.

Review SEC filing

Associated companies

Visual map of known reporting history

MNPRMonopar Therapeutics13 transactions · latest Aug 28, 2026, 11:41 PM
TickerInsiderRoleTypeSharesValueCodeSignals90d returnFiledTrans date
MNPRAnderson Raymond
DIR
exercise10b5-11.74k$0M
Amended Filing Derivative Transaction Direct Ownership+2
—08/2808/25
MNPRAnderson Raymond
DIR
exercise10b5-11.40k$0M
Amended Filing Derivative Transaction Direct Ownership+2
—08/2808/25
MNPRAnderson Raymond
DIR
sale10b5-11.80k-$20.3MS
Amended Filing Direct Ownership Large Holdings Reduction+3
—08/2808/25
MNPRAnderson Raymond
DIR
sale10b5-1646-$7.17MS
Amended Filing Direct Ownership Repeat Seller+1
—08/2808/25
MNPRAnderson Raymond
DIR
sale10b5-1694-$7.63MS
Amended Filing Direct Ownership Repeat Seller+1
—08/2808/25
MNPRAnderson Raymond
DIR
exercise10b5-11.74k$5.22MM
Amended Filing Direct Ownership 10b5-1 Detected
—08/2808/25
MNPRAnderson Raymond
DIR
exercise10b5-11.40k$4.20MM
Amended Filing Direct Ownership 10b5-1 Detected
—08/2808/25
MNPRAnderson Raymond
DIR
sale10b5-11.80k-$20.3MS
Direct Ownership Repeat Seller 10b5-1 Detected
—08/2708/25
MNPRAnderson Raymond
DIR
sale10b5-1646-$7.11MS
Direct Ownership Repeat Seller 10b5-1 Detected
—08/2708/25
MNPRAnderson Raymond
DIR
sale10b5-1694-$7.63MS
Direct Ownership 10b5-1 Detected
—08/2708/25

Anderson Raymond Insider Activity FAQ

SEC Form 4 context

Who is Anderson Raymond?

Anderson Raymond is a reporting owner in SEC Form 4 filings with reporting owner CIK 0001362489.

Which companies has Anderson Raymond reported transactions for?

Monopar Therapeutics

When was Anderson Raymond's latest insider buy?

No open-market insider purchase is available for this period.

When was Anderson Raymond's latest insider sale?

sale at Monopar Therapeutics on Aug 25, 2026 valued at $203,716.

Where can I see the original SEC filings?

Each transaction row links directly to the source SEC filing so the reported Form 4 details can be reviewed.

Are performance metrics included?

This version does not calculate win rates, forward returns, benchmark-adjusted returns, or high-conviction scores.